1. Regulation of BAX and BCL‐2 expression in breast cancer cells by chemotherapy

   • Laura F. Gibson
   • James Fortney
   • Kenneth S. Landreth

   OriginalPaper Pages: 107 - 117

2. Successful co‐treatment with LHRH‐agonist for ovarian over‐stimulation and cystic formation in premenopausal tamoxifen exposure

   • Ilan Cohen
   • Ron Tepper
   • Yoram Beyth

   OriginalPaper Pages: 117 - 123

3. Differentially expressed genes associated with the metastatic phenotype in breast cancer

   • Dawn A. Kirschmann
   • Elisabeth A. Seftor
   • Mary J.C. Hendrix

   OriginalPaper Pages: 125 - 134

4. Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases

   • Bernard Têtu
   • Jacques Brisson
   • Caty Blanchette

   OriginalPaper Pages: 135 - 145

5. Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP‐470 on human breast cancer cells

   • Daigo Yamamoto
   • Yasuhiko Kiyozuka
   • Airo Tsubura

   OriginalPaper Pages: 147 - 158

6. Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation

   • Sehwan Han
   • Kyeongmee Park
   • Young‐Duck Kim

   OriginalPaper Pages: 159 - 165

7. Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors

   • Sylvie Ménard
   • Patrizia Casalini
   • M. Ines Colnaghi

   OriginalPaper Pages: 167 - 175

8. Down‐regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion

   • Harold L. Asch
   • Janet S. Winston
   • Bonnie B. Asch

   OriginalPaper Pages: 177 - 186

9. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT‐B

   • Lesley J Fallowfield
   • Samantha K Leaity
   • David Cella

   OriginalPaper Pages: 187 - 197